Excision repair cross-complementing group-1 (ERCC1) induction kinetics and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatin
| Image |  |
|---|---|
| Description | scientific article published on 17 September 2019 |
| Author/s |
author: John M Mariadason |
| Publication date | September 17, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |